nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—ABCB1—peripheral nervous system neoplasm	0.194	1	CbGaD
Carbamazepine—RALBP1—Vincristine—peripheral nervous system neoplasm	0.148	0.245	CbGbCtD
Carbamazepine—RALBP1—Doxorubicin—peripheral nervous system neoplasm	0.0927	0.153	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0348	0.0575	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0226	0.0374	CbGbCtD
Carbamazepine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0226	0.0374	CbGbCtD
Carbamazepine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0216	0.0356	CbGbCtD
Carbamazepine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.017	0.0281	CbGbCtD
Carbamazepine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0163	0.027	CbGbCtD
Carbamazepine—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0156	0.0257	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0145	0.024	CbGbCtD
Carbamazepine—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0143	0.0236	CbGbCtD
Carbamazepine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0136	0.0225	CbGbCtD
Carbamazepine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0119	0.0196	CbGbCtD
Carbamazepine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0119	0.0196	CbGbCtD
Carbamazepine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0114	0.0188	CbGbCtD
Carbamazepine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0109	0.018	CbGbCtD
Carbamazepine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0104	0.0172	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0104	0.0172	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.00973	0.0161	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00923	0.0152	CbGbCtD
Carbamazepine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00824	0.0136	CbGbCtD
Carbamazepine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0078	0.0129	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00714	0.0118	CbGbCtD
Carbamazepine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00712	0.0118	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00687	0.0113	CbGbCtD
Carbamazepine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00662	0.0109	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00619	0.0102	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00532	0.00878	CbGbCtD
Carbamazepine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00507	0.00838	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00488	0.00806	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00473	0.00782	CbGbCtD
Carbamazepine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00465	0.00768	CbGbCtD
Carbamazepine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00317	0.00524	CbGbCtD
Carbamazepine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00304	0.00502	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00279	0.0046	CbGbCtD
Carbamazepine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0019	0.00314	CbGbCtD
Carbamazepine—RALBP1—RalA downstream regulated genes—HRAS—peripheral nervous system neoplasm	0.000444	0.026	CbGpPWpGaD
Carbamazepine—Ethopropazine—BCHE—peripheral nervous system neoplasm	0.000429	0.333	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—COX2—peripheral nervous system neoplasm	0.000426	0.0249	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—CNTN6—peripheral nervous system neoplasm	0.000364	0.0213	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000356	0.0209	CbGpPWpGaD
Carbamazepine—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000312	0.0183	CbGpPWpGaD
Carbamazepine—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000301	0.0177	CbGpPWpGaD
Carbamazepine—SCN5A—Cardiac Progenitor Differentiation—NCAM1—peripheral nervous system neoplasm	0.000286	0.0168	CbGpPWpGaD
Carbamazepine—SCN9A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000286	0.0167	CbGpPWpGaD
Carbamazepine—SCN4A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000262	0.0154	CbGpPWpGaD
Carbamazepine—Protriptyline—ABCB1—peripheral nervous system neoplasm	0.000247	0.191	CrCbGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—AURKA—peripheral nervous system neoplasm	0.000242	0.0142	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000221	0.013	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000203	0.0119	CbGpPWpGaD
Carbamazepine—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000188	0.011	CbGpPWpGaD
Carbamazepine—Epinastine—ABCB1—peripheral nervous system neoplasm	0.000183	0.142	CrCbGaD
Carbamazepine—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000179	0.0105	CbGpPWpGaD
Carbamazepine—SCN5A—L1CAM interactions—NCAM1—peripheral nervous system neoplasm	0.000178	0.0104	CbGpPWpGaD
Carbamazepine—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000171	0.01	CbGpPWpGaD
Carbamazepine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000165	0.00967	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000158	0.00924	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000145	0.00849	CbGpPWpGaD
Carbamazepine—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00014	0.00821	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000138	0.00807	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000126	0.00738	CbGpPWpGaD
Carbamazepine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00012	0.00702	CbGpPWpGaD
Carbamazepine—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000117	0.00686	CbGpPWpGaD
Carbamazepine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000114	0.00669	CbGpPWpGaD
Carbamazepine—Phenytoin—ABCB1—peripheral nervous system neoplasm	0.000112	0.0866	CrCbGaD
Carbamazepine—SCN9A—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000108	0.00632	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000103	0.00601	CbGpPWpGaD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—ERBB2—peripheral nervous system neoplasm	9.95e-05	0.00583	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	9.94e-05	0.00583	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—NCAM1—peripheral nervous system neoplasm	9.92e-05	0.00581	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—CNTN6—peripheral nervous system neoplasm	9.82e-05	0.00576	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	9.4e-05	0.00551	CbGpPWpGaD
Carbamazepine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	9.05e-05	0.00531	CbGpPWpGaD
Carbamazepine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	9.03e-05	0.00529	CbGpPWpGaD
Carbamazepine—Trimipramine—ABCB1—peripheral nervous system neoplasm	8.92e-05	0.0691	CrCbGaD
Carbamazepine—UGT2B7—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	8.91e-05	0.00522	CbGpPWpGaD
Carbamazepine—Promethazine—ABCB1—peripheral nervous system neoplasm	8.58e-05	0.0665	CrCbGaD
Carbamazepine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.25e-05	0.00484	CbGpPWpGaD
Carbamazepine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	7.86e-05	0.00461	CbGpPWpGaD
Carbamazepine—Desipramine—ABCB1—peripheral nervous system neoplasm	7.8e-05	0.0604	CrCbGaD
Carbamazepine—SCN9A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7.7e-05	0.00451	CbGpPWpGaD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	7.65e-05	0.00449	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	7.08e-05	0.00415	CbGpPWpGaD
Carbamazepine—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	7.07e-05	0.00414	CbGpPWpGaD
Carbamazepine—UGT2B7—NRF2 pathway—HGF—peripheral nervous system neoplasm	6.83e-05	0.004	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—NCAM1—peripheral nervous system neoplasm	6.72e-05	0.00394	CbGpPWpGaD
Carbamazepine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	6.72e-05	0.00394	CbGpPWpGaD
Carbamazepine—Imipramine—ABCB1—peripheral nervous system neoplasm	6.61e-05	0.0512	CrCbGaD
Carbamazepine—RALBP1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.29e-05	0.00368	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	6.27e-05	0.00368	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CD55—peripheral nervous system neoplasm	6.03e-05	0.00353	CbGpPWpGaD
Carbamazepine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	5.89e-05	0.000323	CcSEcCtD
Carbamazepine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.89e-05	0.000323	CcSEcCtD
Carbamazepine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.88e-05	0.000322	CcSEcCtD
Carbamazepine—Weight increased—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000322	CcSEcCtD
Carbamazepine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.000321	CcSEcCtD
Carbamazepine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	5.83e-05	0.00032	CcSEcCtD
Carbamazepine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000319	CcSEcCtD
Carbamazepine—Somnolence—Etoposide—peripheral nervous system neoplasm	5.82e-05	0.000319	CcSEcCtD
Carbamazepine—Asthenia—Vincristine—peripheral nervous system neoplasm	5.8e-05	0.000318	CcSEcCtD
Carbamazepine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000317	CcSEcCtD
Carbamazepine—Infestation—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000315	CcSEcCtD
Carbamazepine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000315	CcSEcCtD
Carbamazepine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.000315	CcSEcCtD
Carbamazepine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.75e-05	0.000315	CcSEcCtD
Carbamazepine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000315	CcSEcCtD
Carbamazepine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.74e-05	0.000314	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000313	CcSEcCtD
Carbamazepine—Rash—Dactinomycin—peripheral nervous system neoplasm	5.7e-05	0.000313	CcSEcCtD
Carbamazepine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.69e-05	0.000312	CcSEcCtD
Carbamazepine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000311	CcSEcCtD
Carbamazepine—Renal failure—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.00031	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.65e-05	0.00031	CcSEcCtD
Carbamazepine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.65e-05	0.00031	CcSEcCtD
Carbamazepine—Fatigue—Etoposide—peripheral nervous system neoplasm	5.64e-05	0.000309	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000309	CcSEcCtD
Carbamazepine—Jaundice—Epirubicin—peripheral nervous system neoplasm	5.61e-05	0.000307	CcSEcCtD
Carbamazepine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	5.61e-05	0.000307	CcSEcCtD
Carbamazepine—UGT2B7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.61e-05	0.00329	CbGpPWpGaD
Carbamazepine—Pain—Etoposide—peripheral nervous system neoplasm	5.6e-05	0.000307	CcSEcCtD
Carbamazepine—Constipation—Etoposide—peripheral nervous system neoplasm	5.6e-05	0.000307	CcSEcCtD
Carbamazepine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000306	CcSEcCtD
Carbamazepine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	5.59e-05	0.000306	CcSEcCtD
Carbamazepine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.54e-05	0.000304	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	5.54e-05	0.00325	CbGpPWpGaD
Carbamazepine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.53e-05	0.000303	CcSEcCtD
Carbamazepine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	5.51e-05	0.000302	CcSEcCtD
Carbamazepine—Haematuria—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000301	CcSEcCtD
Carbamazepine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	5.45e-05	0.000299	CcSEcCtD
Carbamazepine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	5.44e-05	0.00319	CbGpPWpGaD
Carbamazepine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000298	CcSEcCtD
Carbamazepine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000298	CcSEcCtD
Carbamazepine—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	5.42e-05	0.00317	CbGpPWpGaD
Carbamazepine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000296	CcSEcCtD
Carbamazepine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.39e-05	0.000296	CcSEcCtD
Carbamazepine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000295	CcSEcCtD
Carbamazepine—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.37e-05	0.000294	CcSEcCtD
Carbamazepine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000294	CcSEcCtD
Carbamazepine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000293	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.35e-05	0.000293	CcSEcCtD
Carbamazepine—Dizziness—Vincristine—peripheral nervous system neoplasm	5.34e-05	0.000293	CcSEcCtD
Carbamazepine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.33e-05	0.000292	CcSEcCtD
Carbamazepine—Infestation—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000292	CcSEcCtD
Carbamazepine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000292	CcSEcCtD
Carbamazepine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000292	CcSEcCtD
Carbamazepine—Rash—Alitretinoin—peripheral nervous system neoplasm	5.29e-05	0.00029	CcSEcCtD
Carbamazepine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.28e-05	0.000289	CcSEcCtD
Carbamazepine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000289	CcSEcCtD
Carbamazepine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	5.26e-05	0.000288	CcSEcCtD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	5.26e-05	0.00308	CbGpPWpGaD
Carbamazepine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.000288	CcSEcCtD
Carbamazepine—Headache—Alitretinoin—peripheral nervous system neoplasm	5.25e-05	0.000288	CcSEcCtD
Carbamazepine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000287	CcSEcCtD
Carbamazepine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000286	CcSEcCtD
Carbamazepine—Urticaria—Etoposide—peripheral nervous system neoplasm	5.2e-05	0.000285	CcSEcCtD
Carbamazepine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	5.19e-05	0.000284	CcSEcCtD
Carbamazepine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	5.19e-05	0.000284	CcSEcCtD
Carbamazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	5.19e-05	0.00304	CbGpPWpGaD
Carbamazepine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000284	CcSEcCtD
Carbamazepine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.000284	CcSEcCtD
Carbamazepine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.000284	CcSEcCtD
Carbamazepine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000284	CcSEcCtD
Carbamazepine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000284	CcSEcCtD
Carbamazepine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000283	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—MET—peripheral nervous system neoplasm	5.16e-05	0.00302	CbGpPWpGaD
Carbamazepine—Vomiting—Vincristine—peripheral nervous system neoplasm	5.14e-05	0.000282	CcSEcCtD
Carbamazepine—Asthenia—Cisplatin—peripheral nervous system neoplasm	5.13e-05	0.000281	CcSEcCtD
Carbamazepine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.000281	CcSEcCtD
Carbamazepine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	5.1e-05	0.00028	CcSEcCtD
Carbamazepine—Rash—Vincristine—peripheral nervous system neoplasm	5.09e-05	0.000279	CcSEcCtD
Carbamazepine—Dermatitis—Vincristine—peripheral nervous system neoplasm	5.09e-05	0.000279	CcSEcCtD
Carbamazepine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000279	CcSEcCtD
Carbamazepine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000278	CcSEcCtD
Carbamazepine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	5.07e-05	0.000278	CcSEcCtD
Carbamazepine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.000277	CcSEcCtD
Carbamazepine—Headache—Vincristine—peripheral nervous system neoplasm	5.06e-05	0.000277	CcSEcCtD
Carbamazepine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	5.03e-05	0.000276	CcSEcCtD
Carbamazepine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.000274	CcSEcCtD
Carbamazepine—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.98e-05	0.000273	CcSEcCtD
Carbamazepine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000272	CcSEcCtD
Carbamazepine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	4.89e-05	0.00287	CbGpPWpGaD
Carbamazepine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.89e-05	0.000268	CcSEcCtD
Carbamazepine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	4.88e-05	0.000268	CcSEcCtD
Carbamazepine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000267	CcSEcCtD
Carbamazepine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000265	CcSEcCtD
Carbamazepine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	4.82e-05	0.000264	CcSEcCtD
Carbamazepine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000264	CcSEcCtD
Carbamazepine—Nausea—Vincristine—peripheral nervous system neoplasm	4.8e-05	0.000263	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—NCAM1—peripheral nervous system neoplasm	4.8e-05	0.00281	CbGpPWpGaD
Carbamazepine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000263	CcSEcCtD
Carbamazepine—Flushing—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000263	CcSEcCtD
Carbamazepine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000263	CcSEcCtD
Carbamazepine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000262	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.77e-05	0.0028	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.76e-05	0.00279	CbGpPWpGaD
Carbamazepine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.00026	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—MET—peripheral nervous system neoplasm	4.74e-05	0.00278	CbGpPWpGaD
Carbamazepine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	4.72e-05	0.000259	CcSEcCtD
Carbamazepine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000258	CcSEcCtD
Carbamazepine—Asthenia—Etoposide—peripheral nervous system neoplasm	4.7e-05	0.000257	CcSEcCtD
Carbamazepine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	4.69e-05	0.000257	CcSEcCtD
Carbamazepine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000257	CcSEcCtD
Carbamazepine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000257	CcSEcCtD
Carbamazepine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000256	CcSEcCtD
Carbamazepine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000255	CcSEcCtD
Carbamazepine—Chills—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000254	CcSEcCtD
Carbamazepine—Pruritus—Etoposide—peripheral nervous system neoplasm	4.63e-05	0.000254	CcSEcCtD
Carbamazepine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000253	CcSEcCtD
Carbamazepine—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.00025	CcSEcCtD
Carbamazepine—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.54e-05	0.000249	CcSEcCtD
Carbamazepine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000248	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000248	CcSEcCtD
Carbamazepine—Rash—Cisplatin—peripheral nervous system neoplasm	4.5e-05	0.000247	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.5e-05	0.000247	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000246	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000246	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.48e-05	0.000245	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.46e-05	0.000245	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000244	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000243	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000243	CcSEcCtD
Carbamazepine—Tension—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000242	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000241	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.4e-05	0.00258	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	4.38e-05	0.00257	CbGpPWpGaD
Carbamazepine—Nervousness—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000239	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000238	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000238	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000237	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000237	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000237	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000236	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000235	CcSEcCtD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.28e-05	0.00251	CbGpPWpGaD
Carbamazepine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	4.27e-05	0.000234	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—peripheral nervous system neoplasm	4.24e-05	0.000233	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.000232	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000231	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000229	CcSEcCtD
Carbamazepine—Vomiting—Etoposide—peripheral nervous system neoplasm	4.16e-05	0.000228	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000228	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000228	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000228	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000226	CcSEcCtD
Carbamazepine—Rash—Etoposide—peripheral nervous system neoplasm	4.13e-05	0.000226	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—peripheral nervous system neoplasm	4.12e-05	0.000226	CcSEcCtD
Carbamazepine—Headache—Etoposide—peripheral nervous system neoplasm	4.1e-05	0.000225	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000224	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000223	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	4.04e-05	0.000221	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000221	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000221	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	4.02e-05	0.000221	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000221	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000219	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000217	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000215	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.89e-05	0.000213	CcSEcCtD
Carbamazepine—Nausea—Etoposide—peripheral nervous system neoplasm	3.89e-05	0.000213	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.88e-05	0.000213	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000211	CcSEcCtD
Carbamazepine—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.83e-05	0.00225	CbGpPWpGaD
Carbamazepine—Chest pain—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.00021	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.00021	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	3.83e-05	0.00021	CcSEcCtD
Carbamazepine—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	3.82e-05	0.00224	CbGpPWpGaD
Carbamazepine—Agitation—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.00021	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.81e-05	0.000209	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000208	CcSEcCtD
Carbamazepine—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.79e-05	0.00222	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.77e-05	0.00221	CbGpPWpGaD
Carbamazepine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	3.74e-05	0.000205	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000205	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000204	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	3.72e-05	0.000204	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000203	CcSEcCtD
Carbamazepine—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	3.68e-05	0.00216	CbGpPWpGaD
Carbamazepine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.000201	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.000201	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.0002	CcSEcCtD
Carbamazepine—Infection—Epirubicin—peripheral nervous system neoplasm	3.64e-05	0.0002	CcSEcCtD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.64e-05	0.00213	CbGpPWpGaD
Carbamazepine—Shock—Epirubicin—peripheral nervous system neoplasm	3.61e-05	0.000198	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.6e-05	0.000198	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000197	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000197	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.59e-05	0.000197	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.58e-05	0.000196	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000195	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000194	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000194	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000194	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000194	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000193	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.000193	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000192	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.46e-05	0.00203	CbGpPWpGaD
Carbamazepine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	3.46e-05	0.00019	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000188	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000188	CcSEcCtD
Carbamazepine—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.4e-05	0.00199	CbGpPWpGaD
Carbamazepine—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000186	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.39e-05	0.000186	CcSEcCtD
Carbamazepine—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	3.38e-05	0.00198	CbGpPWpGaD
Carbamazepine—Infection—Doxorubicin—peripheral nervous system neoplasm	3.37e-05	0.000185	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.34e-05	0.000183	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—peripheral nervous system neoplasm	3.34e-05	0.000183	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000182	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.32e-05	0.000182	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.32e-05	0.000182	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.31e-05	0.000182	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.3e-05	0.00194	CbGpPWpGaD
Carbamazepine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000181	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.29e-05	0.000181	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.00018	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	3.27e-05	0.000179	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—peripheral nervous system neoplasm	3.26e-05	0.000179	CcSEcCtD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.25e-05	0.0019	CbGpPWpGaD
Carbamazepine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000177	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000177	CcSEcCtD
Carbamazepine—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	3.21e-05	0.00188	CbGpPWpGaD
Carbamazepine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.000175	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000174	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.17e-05	0.000174	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.16e-05	0.000173	CcSEcCtD
Carbamazepine—Pain—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000172	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000172	CcSEcCtD
Carbamazepine—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	3.13e-05	0.00183	CbGpPWpGaD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	3.09e-05	0.00017	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000168	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.05e-05	0.000167	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.03e-05	0.000166	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000166	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.02e-05	0.000165	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3e-05	0.000164	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000164	CcSEcCtD
Carbamazepine—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	2.97e-05	0.00174	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.96e-05	0.00174	CbGpPWpGaD
Carbamazepine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000162	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.000161	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.93e-05	0.00016	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.91e-05	0.00016	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000159	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000159	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000159	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000159	CcSEcCtD
Carbamazepine—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.87e-05	0.00168	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.83e-05	0.00166	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.82e-05	0.00166	CbGpPWpGaD
Carbamazepine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000153	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.78e-05	0.000152	CcSEcCtD
Carbamazepine—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.77e-05	0.00162	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	2.74e-05	0.0016	CbGpPWpGaD
Carbamazepine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	2.7e-05	0.000148	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000148	CcSEcCtD
Carbamazepine—RALBP1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.69e-05	0.00158	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.69e-05	0.00158	CbGpPWpGaD
Carbamazepine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000147	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000147	CcSEcCtD
Carbamazepine—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.63e-05	0.00154	CbGpPWpGaD
Carbamazepine—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.63e-05	0.000144	CcSEcCtD
Carbamazepine—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	2.62e-05	0.00154	CbGpPWpGaD
Carbamazepine—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.6e-05	0.000142	CcSEcCtD
Carbamazepine—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.59e-05	0.00152	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	2.58e-05	0.00151	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.53e-05	0.00148	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	2.53e-05	0.00148	CbGpPWpGaD
Carbamazepine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000138	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	2.5e-05	0.000137	CcSEcCtD
Carbamazepine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	2.49e-05	0.00146	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.47e-05	0.00145	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.47e-05	0.00145	CbGpPWpGaD
Carbamazepine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.44e-05	0.000133	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000133	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.4e-05	0.000132	CcSEcCtD
Carbamazepine—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.4e-05	0.00141	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.35e-05	0.00138	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	2.35e-05	0.00138	CbGpPWpGaD
Carbamazepine—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.33e-05	0.000128	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.32e-05	0.000127	CcSEcCtD
Carbamazepine—Rash—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000127	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.31e-05	0.000127	CcSEcCtD
Carbamazepine—Headache—Epirubicin—peripheral nervous system neoplasm	2.3e-05	0.000126	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	2.29e-05	0.00134	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.26e-05	0.00133	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	2.25e-05	0.00132	CbGpPWpGaD
Carbamazepine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000123	CcSEcCtD
Carbamazepine—Nausea—Epirubicin—peripheral nervous system neoplasm	2.18e-05	0.000119	CcSEcCtD
Carbamazepine—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.18e-05	0.00128	CbGpPWpGaD
Carbamazepine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.16e-05	0.000118	CcSEcCtD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.15e-05	0.00126	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.14e-05	0.00125	CbGpPWpGaD
Carbamazepine—Rash—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000117	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.14e-05	0.000117	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—peripheral nervous system neoplasm	2.13e-05	0.000117	CcSEcCtD
Carbamazepine—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.12e-05	0.00124	CbGpPWpGaD
Carbamazepine—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.1e-05	0.00123	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.09e-05	0.00123	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.09e-05	0.00122	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.05e-05	0.0012	CbGpPWpGaD
Carbamazepine—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.02e-05	0.000111	CcSEcCtD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.01e-05	0.00118	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.95e-05	0.00114	CbGpPWpGaD
Carbamazepine—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	1.93e-05	0.00113	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.91e-05	0.00112	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.88e-05	0.0011	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	1.87e-05	0.0011	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.87e-05	0.0011	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.82e-05	0.00107	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	1.79e-05	0.00105	CbGpPWpGaD
Carbamazepine—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.79e-05	0.00105	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	1.79e-05	0.00105	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	1.73e-05	0.00101	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.72e-05	0.00101	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.68e-05	0.000982	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.67e-05	0.000978	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	1.66e-05	0.000972	CbGpPWpGaD
Carbamazepine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	1.64e-05	0.000963	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.62e-05	0.00095	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.5e-05	0.000877	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.45e-05	0.000848	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.41e-05	0.000827	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	1.4e-05	0.000821	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.38e-05	0.000811	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.38e-05	0.000806	CbGpPWpGaD
Carbamazepine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.36e-05	0.000798	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.36e-05	0.000795	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.000793	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.35e-05	0.000789	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.34e-05	0.000784	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.33e-05	0.000778	CbGpPWpGaD
Carbamazepine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.32e-05	0.000775	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.32e-05	0.000773	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	1.32e-05	0.000772	CbGpPWpGaD
Carbamazepine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	1.31e-05	0.000766	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.3e-05	0.00076	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.29e-05	0.000755	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.28e-05	0.000748	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000747	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000732	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-05	0.000722	CbGpPWpGaD
Carbamazepine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.21e-05	0.000712	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.2e-05	0.000704	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.18e-05	0.000694	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.17e-05	0.000687	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.13e-05	0.000664	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.13e-05	0.00066	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.12e-05	0.000658	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.1e-05	0.000642	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.08e-05	0.000634	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.08e-05	0.00063	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.07e-05	0.00063	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.06e-05	0.000624	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.06e-05	0.000619	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.05e-05	0.000613	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000605	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.02e-05	0.000598	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1e-05	0.000588	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	9.78e-06	0.000573	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	9.65e-06	0.000566	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.61e-06	0.000564	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	9.58e-06	0.000561	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	9.53e-06	0.000559	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	9.42e-06	0.000552	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.36e-06	0.000549	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	9.33e-06	0.000547	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	9.14e-06	0.000536	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.14e-06	0.000536	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	9e-06	0.000528	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	8.8e-06	0.000516	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.7e-06	0.00051	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.56e-06	0.000502	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.39e-06	0.000492	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	8.38e-06	0.000491	CbGpPWpGaD
Carbamazepine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.23e-06	0.000483	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	8.19e-06	0.00048	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	8.15e-06	0.000478	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.9e-06	0.000463	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	7.81e-06	0.000458	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.55e-06	0.000443	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	7.52e-06	0.000441	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	7.35e-06	0.000431	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	7.21e-06	0.000423	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	7.1e-06	0.000416	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	7.08e-06	0.000415	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	6.92e-06	0.000406	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.89e-06	0.000404	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.76e-06	0.000396	CbGpPWpGaD
Carbamazepine—RALBP1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.67e-06	0.000391	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	6.66e-06	0.00039	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.6e-06	0.000387	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	6.51e-06	0.000382	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	6.33e-06	0.000371	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.29e-06	0.000369	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.18e-06	0.000362	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.03e-06	0.000353	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6e-06	0.000351	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.82e-06	0.000341	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	5.8e-06	0.00034	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	5.78e-06	0.000339	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.72e-06	0.000335	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	5.64e-06	0.00033	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	5.44e-06	0.000319	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	5.35e-06	0.000314	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	5.33e-06	0.000313	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.31e-06	0.000311	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.22e-06	0.000306	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.21e-06	0.000306	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.11e-06	0.000299	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.03e-06	0.000295	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.98e-06	0.000292	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.94e-06	0.000289	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.91e-06	0.000288	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	4.88e-06	0.000286	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.66e-06	0.000273	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	4.6e-06	0.00027	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	4.59e-06	0.000269	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	4.52e-06	0.000265	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.17e-06	0.000244	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.11e-06	0.000241	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.03e-06	0.000236	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.01e-06	0.000235	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.98e-06	0.000233	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.92e-06	0.00023	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.81e-06	0.000223	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	3.75e-06	0.00022	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	3.68e-06	0.000215	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.22e-06	0.000189	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.2e-06	0.000188	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.14e-06	0.000184	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.07e-06	0.00018	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.03e-06	0.000177	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	2.9e-06	0.00017	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.47e-06	0.000145	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.42e-06	0.000142	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	1.98e-06	0.000116	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.47e-06	8.6e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.43e-06	8.41e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.24e-06	7.28e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.11e-06	6.5e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.08e-06	6.34e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.01e-06	5.93e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	8.64e-07	5.06e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	6.67e-07	3.91e-05	CbGpPWpGaD
